ArticleExperimental & molecular medicine2025
Targeting DDOST improves the efficacy of lenvatinib and immunotherapy in hepatocellular carcinoma.
Jun Pu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it